Solifenacin succinateProduct ingredient for Solifenacin
- Name
- Solifenacin succinate
- Drug Entry
- Solifenacin
Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.3 It has a long duration of action as it is usually taken once daily.3
Solifenacin was granted FDA approval on 19 November 2004.3
- Accession Number
- DBSALT001639
- Structure
Structure for Solifenacin succinate (DBSALT001639)
- Synonyms
- Solifenacin succinate